Announced Tue, 12 May · 14:55 IST

Beta Drugs Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

BETA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+6.6%1-day move

₹1326.00

prior close

₹1360.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.4+0.6+0.0+0.1+6.6+6.3-5.0-4.2-11.0-7.2+9.4+33.6+76.5—

Up moveDown movePending

AI summary

Beta Drugs Limited has scheduled a Q4 & FY26 earnings conference call for Friday, 15th May 2026 at 2:30 PM IST. The call will be hosted by PhillipCapital (India) Private Limited and will feature key company executives including Chairman & MD Rahul Batra, CFO Nipun Arora, and Director (Sales & Marketing) Ashutosh Shukla. The management will discuss the company's operational and financial performance for Q4 and full year FY26. The announcement was made under SEBI LODR Regulation 30(6), which requires disclosure of investor meetings and earnings calls.

Likely market impact

This is a routine disclosure providing retail investors an opportunity to participate in or track the Q4 & FY26 earnings discussion. The participation of top leadership indicates transparency and openness to shareholder engagement, which is typically viewed positively by the market.